Bottom line
How much do GGHCX and LYFIX overlap?
17% of their top holdings overlap by weight. 5 securities appear in both funds' top 25, making up 14.5% of GGHCX's assets and 19.8% of LYFIX's. They are substantially different portfolios, so owning both adds real diversification.
Updated Nov 22, 2026
Overlap at a glance
Holdings GGHCX and LYFIX have in common
| Holding | % of GGHCX | % of LYFIX | Overlap |
|---|---|---|---|
| AbbVie Inc. | 4.03% | 1.95% | 1.95% |
| Gilead Sciences, Inc. | 3.63% | 5.53% | 3.63% |
| argenx SE | 3.24% | 3.59% | 3.24% |
| Vertex Pharmaceuticals Inc. | 2.01% | 5.33% | 2.01% |
| Axsome Therapeutics, Inc. | 1.58% | 3.43% | 1.58% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in GGHCX
- Eli Lilly and Co. — 10.59%
- Johnson & Johnson — 6.76%
- UnitedHealth Group Inc. — 6.17%
- Invesco Private Prime Fund — 4.67%
- Merck & Co., Inc. — 4.59%
- CVS Health Corp. — 2.52%
- Welltower Inc. — 2.34%
- BrightSpring Health Services, Inc. — 2.20%
- Royalty Pharma PLC — 2.13%
- Cardinal Health, Inc. — 2.10%
- Guardant Health, Inc. — 2.04%
- Invesco Private Government Fund — 1.80%
- Edwards Lifesciences Corp. — 1.56%
- Invesco Treasury Portfolio — 1.56%
- Thermo Fisher Scientific Inc. — 1.55%
Only in LYFIX
- Astrazeneca Plc — 4.63%
- First American Funds Inc — 4.26%
- Roivant Sciences Ltd — 3.67%
- Neurocrine Biosciences Inc — 3.51%
- Incyte Corp — 3.51%
- Apogee Therapeutics Inc — 3.28%
- Ionis Pharmaceuticals Inc — 2.62%
- Ascendis Pharma A/s — 2.62%
- Insmed Inc — 2.60%
- Protagonist Therapeutics Inc — 2.41%
- Personalis Inc — 2.27%
- Rhythm Pharmaceuticals Inc — 2.25%
- Jazz Pharmaceuticals Plc — 1.87%
- Amgen Inc — 1.83%
- Biogen Inc — 1.80%
Asset mix
| Asset type | GGHCX | LYFIX |
|---|---|---|
| Stocks | 97.5% | 95.8% |
| Cash & short-term funds | 8.8% | 4.3% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Country mix
| Country | GGHCX | LYFIX |
|---|---|---|
| US | 93.5% | 76.0% |
| NL | 3.4% | 4.7% |
| GB | 3.1% | 4.6% |
| BM | — | 3.7% |
| FR | — | 2.8% |
| CH | 2.7% | — |
| DK | 1.1% | 2.6% |
| IE | 0.6% | 2.4% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do GGHCX and LYFIX overlap?
What stocks do GGHCX and LYFIX have in common?
Should I own both GGHCX and LYFIX?
Which holds more stocks, GGHCX or LYFIX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.